Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets-Reference-Cited by-同舟云学术

Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets

Published:2019-02-08 Issue:1 Volume:12 Page:
ISSN:1755-8794
Container-title:BMC Medical Genomics
language:en
Short-container-title:BMC Med Genomics

Author:

Nava Miguel,Dutta Pranabananda,Zemke Nathan R.,Farias-Eisner Robin,Vadgama Jaydutt V.,Wu Yanyuan

Funder

National Institute on Minority Health and Health Disparities

National Cancer Institute

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1186/s12920-019-0477-8.pdf

Reference59 articles.

1. Brennan PJ, Kumogai T, Berezov A, Murali R, Greene MI. HER2/neu: mechanisms of dimerization/oligomerization. Oncogene. 2000;19:6093–101.

2. Yarden Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur. J. Cancer. 2001;37(Suppl 4):S3–8.

3. Rubin I, Yarden Y. The basic biology of HER2. Ann Oncol. 2001;12:3–8.

4. Nagy P, Jenei A, Damjanovich S, Jovin TM, Szôlôsi J. Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy. Pathol Oncol Res. 1999;5:255–71.

5. Rexer BN, Arteaga CL. Intrinsic and acquired resistance to HER2-targeted therapies in HER2 gene-amplified breast cancer: mechanisms and clinical implications. Crit. Rev. Oncog. [Internet]. 2012;17:1–16. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3394454&tool=pmcentrez&rendertype=abstract

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S100A6 mediated epithelial-mesenchymal transition affects chemosensitivity of colorectal cancer to oxaliplatin;Gene;2024-07

2. How does understanding epigenetics help circumvent HER-2 antibody resistance?;Overcoming Cancers Resistant to HER-2 Antibodies;2024

3. S100 Proteins in Cancer;Advances in Clinical Medicine;2024

4. Influence of Sodium New Houttuyfonate as a New EGFR-TK Inhibitor on the Apoptosis and Autophagy of MCF-7 Cells and Its Toxicity to Caenorhabditis elegans;Processes;2023-05-29

5. FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways;Clinical and Translational Medicine;2023-05